GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (NAS:AVGR) » Definitions » Debt-to-Equity

Avinger (Avinger) Debt-to-Equity : -4.13 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avinger Debt-to-Equity?

Avinger's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $15.91 Mil. Avinger's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.84 Mil. Avinger's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-4.05 Mil. Avinger's debt to equity for the quarter that ended in Mar. 2024 was -4.13.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Avinger's Debt-to-Equity or its related term are showing as below:

AVGR' s Debt-to-Equity Range Over the Past 10 Years
Min: -11.21   Med: 1.09   Max: 16.49
Current: -4.13

During the past 12 years, the highest Debt-to-Equity Ratio of Avinger was 16.49. The lowest was -11.21. And the median was 1.09.

AVGR's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs AVGR: -4.13

Avinger Debt-to-Equity Historical Data

The historical data trend for Avinger's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Debt-to-Equity Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 1.30 1.59 3.95 -2.48

Avinger Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.13 -2.56 -11.21 -2.48 -4.13

Competitive Comparison of Avinger's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Avinger's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avinger's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avinger's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Avinger's Debt-to-Equity falls into.



Avinger Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Avinger's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Avinger's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avinger  (NAS:AVGR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Avinger Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Avinger's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (Avinger) Business Description

Traded in Other Exchanges
N/A
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Executives
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Nabeel Paul Subainati officer: Vice President, Finance 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
James Cullen director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Mark Weinswig officer: Chief Financial Officer EMCORE CORP, 10420 RESEARCH ROAD, SE, ALBUQUERQUE NM 87123
Himanshu Patel officer: Chief Technology Officer C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Jeffrey M Soinski director, officer: President and CEO 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Tamara Elias director 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Simpson John B Ph D Md director, 10 percent owner C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Matthew Ferguson officer: CBO, CFO & Treasurer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
John D. Simpson officer: Sr. VP, Sales & Marketing C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063